Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4,129 JPY | +1.45% | +0.10% | +1.85% |
May. 10 | Takeda Pharmaceutical's Attributable Profit Falls 55% in Fiscal 2024 | MT |
May. 09 | Health Care Climbs as Obesity-Drug Optimism Returns - Health Care Roundup | DJ |
Sales 2024 | 4,264B 27.36B | Sales 2025 * | 4,058B 26.04B | Capitalization | 6,478B 41.58B |
---|---|---|---|---|---|
Net income 2024 | 144B 925M | Net income 2025 * | 155B 997M | EV / Sales 2024 | 1.54 x |
Net Debt 2024 * | 3,771B 24.2B | Net Debt 2025 * | 4,027B 25.85B | EV / Sales 2025 * | 2.59 x |
P/E ratio 2024 |
45.4
x | P/E ratio 2025 * |
40.7
x | Employees | 49,095 |
Yield 2024 * |
4.55% | Yield 2025 * |
4.6% | Free-Float | 99.12% |
Latest transcript on Takeda Pharmaceutical Company Limited
1 day | +1.45% | ||
1 week | +0.10% | ||
Current month | -0.58% | ||
1 month | -0.55% | ||
3 months | -3.05% | ||
6 months | -0.58% | ||
Current year | +1.85% |
Managers | Title | Age | Since |
---|---|---|---|
Christophe Weber
CEO | Chief Executive Officer | 57 | 14-03-31 |
Gabriele Ricci
CTO | Chief Tech/Sci/R&D Officer | 45 | 22-01-31 |
Mwana Lugogo
CMP | Compliance Officer | 54 | 11-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 71 | 16-05-31 | |
Ian Clark
BRD | Director/Board Member | 62 | 18-12-31 |
Steven Gillis
BRD | Director/Board Member | 71 | 18-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
24.44% | 0 M€ | +11.43% | ||
5.00% | 0 M€ | +23.89% | ||
3.80% | 0 M€ | +20.85% | ||
3.43% | 0 M€ | +13.17% | ||
3.26% | 0 M€ | +20.78% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 4,129 | +1.45% | 8,275,700 |
24-05-09 | 4,070 | +0.42% | 3,465,100 |
24-05-08 | 4,053 | -1.12% | 5,332,100 |
24-05-07 | 4,099 | -0.63% | 6,576,000 |
24-05-02 | 4,125 | -0.43% | 3,157,000 |
Delayed Quote Japan Exchange, May 10, 2024 at 02:00 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.85% | 41.56B | |
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
+7.68% | 166B |
- Stock Market
- Equities
- 4502 Stock